Tissue Engineering and Regeneration: Technologies and Global Markets
The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate(CAGR) of 22.3%.
- An overview of the global market for tissue engineering and regeneration, and related technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Information on the specific drivers, trends, and challenges for different segments of the market.
- Valuable insight into future trends, details on products, and information on therapies available in the field of tissue engineering.
- Analysis of the competitive environments, including new and potential markets for novel therapies and treatments.
- Comprehensive profiles of major players in the industry.
SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes key technologies involved in stem cell therapies and cell therapies. It analyzes the clinical trials and patents conducted in respective geographies. The report is an in-depth analysis of key companies operating in the global tissue engineering and regeneration market. It includes in-depth patent analysis that focuses on providing extensive technological trends across years and across regions, including the U.S., Europe and Japan.
The tissue engineering and regeneration market is mainly segmented into three classes: synthetic, genetically modified and biological materials. Synthetic materials are further categorized into biodegradable synthetic polymers, scaffold (medical poly lactic acid), artificial vascular graft materials and hydrogeltechnology. The biologically derived materials are segmented into, xenogenic tissue and collagen. The ablation device application market is further segmented on the basis of various applications for in-depth analysis of technology markets. The market study is detailed for application based on procedures, as well as its further implication on the therapeutic area. These two segments are also discussed in detailed for the forecast period. The market is segmented by region into the Americas, Europe, Asia-Pacific and ROW. Companies profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, CeraPedics, Cook Biotech, CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.
Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market, and in the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to help market players make strategic decision. She holds an MBA in Marketing.
The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.